AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
2.130
0.00 (0.00%)
Jul 2, 2024, 4:30 PM EDT - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $63.54 million as of July 2, 2024. Its market cap has decreased by -56.09% in one year.
Market Cap
63.54M
Enterprise Value
-50.67M
1-Year Change
-56.09%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $63.54M, a decrease of -77.40%. That is a compound annual growth rate of -48.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 63.50M | -89.58% |
Dec 29, 2023 | 609.40M | 229.58% |
Dec 30, 2022 | 184.90M | -34.22% |
Mar 25, 2022 | 281.10M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BioAtla | 64.96M |
HeartBeam | 64.51M |
Theratechnologies | 64.37M |
Monogram Orthopaedics | 63.97M |
MDxHealth | 63.58M |
Genelux | 63.21M |
Entera Bio | 63.04M |
Gritstone bio | 62.97M |